Social Anxiety and Avoidance in Head and Neck Cancer Patients
- Determine the relationship between treatment-provoked social anxiety and avoidance in
patients previously treated for head and neck cancer.
- Determine the relationship between pre-cancer psychiatric diagnosis and post-treatment
social anxiety and avoidance in these patients.
- Determine the effect of social anxiety and/or avoidance on the quality of life of these
- Investigate the specificity of these relationships in patients with head and neck
cancer by comparing patients with head and neck cancer to patients with lung cancer.
OUTLINE: This is a cross-sectional study. Patients are stratified according to prior
treatment type (significantly impairing [surgery] vs less impairing
Patients undergo a face-to-face interview with a mental health clinician over 2 hours.
Patients complete multiple psychiatric/psychological assessments during the interview,
including the Structured Clinical Interview for DSM-IV (SCID); the Liebowitz Social Anxiety
Scale (SAS); the Performance Status Scale for Head and Neck Cancer Patients (PSS-HN); the
Social Phobia and Anxiety Inventory (SPAI); the State-Trait Anxiety Inventory (STAI);
Response to Stress Questionnaire, Cancer Version (RSQ-CV); the Functional Assessment of
Cancer Therapy (FACT-HNC (head neck cancer) or LC); the Voice Handicap Index (VHI); and the
Body Image Scale (BIS).
Cancer treatment and medical history information are gathered from patients' medical
Observational Model: Case Control, Time Perspective: Prospective
Level of social anxiety and avoidance in HNC patients post-treatment
Measured by the Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory, containing 24 items with each item separately rated for fear as 0 (none), 1 (mild), 2 (moderate) to 3 (severe)and for avoidance behavior as 0 (never), 1 (occasionally), 2 (often), to 3 (usually). Scores are summed with lower values indicating lower levels of social anxiety and avoidance.
at study entry, day 1
Kirsten Haman, PhD
Vanderbilt-Ingram Cancer Center
United States: Federal Government
VICC HN 0397
|Vanderbilt-Ingram Cancer Center||Nashville, Tennessee 37232-6838|
|MBCCOP - Meharry Medical College - Nashville||Nashville, Tennessee 37208-3599|